Get started
Author

Jacob Nøhr-Meldgaard

Observed names: JACOB NØHR-MELDGAARD, Jacob N. Meldgaard
Institution: Gubra (Denmark)
OpenAlex ID: A5025188296
PGC-1α regulates mitochondrial properties beyond biogenesis with aging and exercise training
2019 · Jens Frey Halling, Henrik Jessen, et al. · American Journal of Physiology-Endocrinology and Metabolism · 83
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis
2023 · Henrik H. Hansen, Susanne Pors, et al. · Scientific Reports · 38
PDF
Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis
2024 · Malte Hasle Nielsen, Jacob Nøhr-Meldgaard, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 20
PGC-1αin hepatic UPR during high-fat high-fructose diet and exercise training in mice
2018 · Caroline M. Kristensen, Maja M. Dethlefsen, et al. · Physiological Reports · 19
PDF
PGC-1α in exercise and fasting-induced regulation of hepatic UPR in mice
2018 · Caroline M. Kristensen, Mette A. Olsen, et al. · Pflügers Archiv - European Journal of Physiology · 16
PDF
Preclinical efficacy and clinical translatability of resmetirom in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
2023 · Michael Feigh, Jacob Nøhr-Meldgaard, et al. · Journal of Hepatology · 2
The Adenine-Induced Mouse Model of CKD Shows Rapid Development of Impaired Kidney Function, Renal Fibrosis, Muscle Wasting, and Anemia
2023 · Maria K. Ougaard, Frederikke E. Sembach, et al. · Journal of the American Society of Nephrology · 1
SAT-173 Hepatoprotective effects of Efruxifermin in the CDAA-HFD mouse model of advanced MASH with progressive fibrosis
2026 · Monika Lewinska, Jacob Nøhr-Meldgaard, et al. · Journal of Hepatology
SAT-142 Semaglutide improves metabolic and histological outcomes and reverses clinically relevant biomarker alterations in the GAN dietinduced obese and biopsy-confirmed mouse model of MASH
2026 · Henrik H. Hansen, Jacob Nøhr-Meldgaard, et al. · Journal of Hepatology
Therapeutic efficacy, biomarker signatures, and translatability of semaglutide in the liver biopsy-confirmed GAN DIO-MASH mouse model
2026 · Jens Bjelke Kristensen, Jacob Nøhr-Meldgaard, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology
Lipidated interleukin-22 reduces body weight and spares lean mass in mice by a novel gut-acting mechanism additive to GLP-1 agonism
2026 · Daniela Hass, Andreas N. Madsen, et al. · Molecular Therapy
2170-LB: Tirzepatide Reduces Tumor Burden in the GAN Diet-Induced Obese and Biopsy-Confirmed Mouse Model of MASH-HCC with Advanced Fibrosis
2025 · MICHAEL FEIGH, NICOLAS O. ESKESEN, et al. · Diabetes
FRI-414 Reproducible hepatoprotective effects and clinical translatability of long-term semaglutide treatment in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
2025 · Michael Feigh, Jacob Nøhr-Meldgaard, et al. · Journal of Hepatology
FRI-413 Hepatoprotective effects of fatty acid synthase inhibitor TVB-3664 in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
2025 · Michael Feigh, Kristoffer Voldum-Clausen, et al. · Journal of Hepatology
FRI-383 Comparative anti-fibrotic action of resmetirom, semaglutide, tirzepatide and efruxifermin in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
2025 · Jacob Nøhr-Meldgaard, Gaye Saginc Giannoustas, et al. · Journal of Hepatology
FRI-370 Hepatoprotective effects of efruxifermin treatment in GAN diet-induced obese and biopsy-confirmed mouse model of MASH
2025 · Henrik B. Hansen, Susanne Pors, et al. · Journal of Hepatology
THU-202 Prophylactic and therapeutic hepatoprotective effects of the dual FXR/TGR5 agonist INT-767 in the GAN diet-induced ob/ob mouse model of advanced MASH with progressive fibrosis
2024 · Jacob Nøhr-Meldgaard, Susanne Pors, et al. · Journal of Hepatology
Dose-Dependent Nephroprotective Effects of an ALK5 Inhibitor in the Unilateral Ureteral Obstruction (UUO) Mouse Model of Kidney Fibrosis
2023 · Stine T. Bak, Jacob Nøhr-Meldgaard, et al. · Journal of the American Society of Nephrology
Prophylactic and therapeutic hepatoprotective effects of lanifibranor in the CDAA-HFD mouse model of advanced NASH with progressive fibrosis
2023 · Jacob Nøhr-Meldgaard, Ditte Denker Thorbek, et al. · Journal of Hepatology
Differential hepatoprotective effects of semaglutide and lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH with advanced fibrosis and HCC
2023 · Malte H. Nielsen, Susanne Pors, et al. · Journal of Hepatology
Efficacy and reproducibility of AI-assisted Gubra Histopathological Objective Scoring Technique (GHOST) in preclinical rodent models of NASH
2023 · Susanne Pors, Jacob Nøhr-Meldgaard, et al. · Journal of Hepatology
Establishment of an Adenine-Induced Nephropathy Mouse Model of CKD With Reduced GFR
2022 · Jacob Nøhr-Meldgaard, Henrik H. Hansen, et al. · Journal of the American Society of Nephrology
Works count: 22
Citation count: 179
H-index: 5
I10-index: 5
Year
Topic
Type